Ekso Bionics (NASDAQ:EKSO) Announces Earnings Results

Ekso Bionics (NASDAQ:EKSO) posted its earnings results on Monday. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.02), Yahoo Finance reports. The company had revenue of $4.95 million for the quarter, compared to analysts’ expectations of $5.34 million. Ekso Bionics had a negative return on equity of 92.08% and a negative net margin of 68.41%. During the same quarter in the prior year, the company earned ($0.31) EPS.

Ekso Bionics Stock Performance

Shares of Ekso Bionics stock opened at $1.05 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.42. Ekso Bionics has a 52-week low of $0.62 and a 52-week high of $3.13. The company’s 50 day moving average price is $1.15 and its 200-day moving average price is $1.47.

Analyst Ratings Changes

EKSO has been the subject of several analyst reports. StockNews.com initiated coverage on shares of Ekso Bionics in a report on Tuesday. They issued a “hold” rating for the company. Lake Street Capital started coverage on Ekso Bionics in a report on Monday, June 24th. They issued a “buy” rating and a $2.50 price objective for the company. Finally, HC Wainwright reissued a “buy” rating and set a $10.00 price objective on shares of Ekso Bionics in a report on Tuesday.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.